Marcus Shaker’s research while affiliated with Dartmouth–Hitchcock Medical Center and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (186)


A cost-effectiveness analysis of non-injectable epinephrine for food allergy
  • Article

February 2025

·

6 Reads

Journal of Allergy and Clinical Immunology

Marcus Shaker

·

Nick Rider

·

David Golden

·

[...]

·

Matthew Greenhawt



Scenario analyses
Cost-effectiveness of watchful waiting versus immediate emergency department transfer after epinephrine autoinjector use in Canada
  • Article
  • Full-text available

January 2025

·

5 Reads

Allergy Asthma and Clinical Immunology

Background Until recently, immediate emergency department (ED) transfer after food-related anaphylactic reactions was recommended regardless of symptom resolution following use of an epinephrine autoinjector (EAI). We evaluated the cost-effectiveness of delayed ED transfer after EAI use in non-medical settings (watchful waiting) compared to immediate ED transfer among pediatric patients with food allergies in Canada. Methods We developed a probabilistic Markov model of individuals starting at age of one year who are at risk of severe food-related allergic reactions requiring epinephrine. We evaluated medical costs (in 2022 Canadian dollars) and quality-adjusted life years (QALY) of each strategy over a 20-year horizon. In the base case, we assumed a tenfold increase in food allergy fatality for patients under watchful waiting, which we increased to 100- to 1,000-fold in sensitivity analysis. The analysis was conducted from the Canadian healthcare system perspective with a 1.5% annual discount rate and a willingness-to-pay (WTP) threshold of 50,000perQALY.ResultsImmediateEDtransferfollowingEAIuseresultedinadecreasedriskoffoodallergyfatalityof9.2×105over20years,whichisequivalentto<1fatalityper200,000patientyears.Watchfulwaitingresultedincostsavingsof50,000 per QALY. Results Immediate ED transfer following EAI use resulted in a decreased risk of food allergy fatality of 9.2 × 10 − 5 over 20 years, which is equivalent to < 1 fatality per 200,000 patient-years. Watchful waiting resulted in cost savings of 1,157 per patient and a QALY loss of 7.28 × 10 − 4 ; an incremental cost per QALY saved of 1,589,854.TheincrementalcostperdeathpreventedwithimmediateEDtransferwas1,589,854. The incremental cost per death prevented with immediate ED transfer was 12,586,613. Watchful waiting remained cost-effective in all sensitivity and scenario analyses, except under extreme increases in fatality risk of 500-fold and 1,000-fold. Conclusions Watchful waiting for symptom re-occurrence following EAI administration in non-medical settings is cost-effective.

Download


Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy

December 2024






Citations (44)


... Food allergies are immune system disorders triggered by protein antigens in food, resulting in a range of clinical symptoms that can affect the gastrointestinal tract, respiratory system, skin, and central nervous system (1). Currently, there is no complete cure for food allergies. ...

Reference:

Uncovering the mechanisms underlying the efficacy of probiotic strains in mitigating food allergies: an emphasis on gut microbiota and indoleacrylic acid
Food Allergy, Nutrition, Psychology, and Health
  • Citing Article
  • October 2024

... Shared decision-making is an important paradigm of care that touches many aspects of allergy immunology. [42][43][44][45][46][47] This approach to practice engages patients as experts in their own preferences and values, leveraging patient insights with clinician expertise provided by their health-care professional. 42 Importantly, shared decision-making is appropriate under conditions of equipoise. ...

Shared decision-making, communicating risk, and food allergy in 2023

... Given that many of the studies for the role of BM and BE are observational and there are methodological concerns with prospective studies, a recent systematic review concluded there is very low certainty of evidence supporting the safety and efficacy of using milk and egg ladders, or baked and lesser-cooked forms as OIT to promote tolerance to the uncooked form [62]. ...

The Safety and Efficacy of Baked Egg and Milk Dietary Advancement Therapy: A Systematic Review and Meta-Analysis
  • Citing Article
  • June 2024

... The infection control practices questionnaire was adapted from a validated tool (Tahoun et al., 2019) and utilized a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). The questionnaire included items related to hygiene practices such as handwashing, cleaning, food safety, and diaper-changing techniques (11,12). ...

Oral Food Immunotherapy in Patients with Atopic Dermatitis
  • Citing Article
  • June 2024

Annals of Allergy Asthma & Immunology

... Early OIT studies have shown more favorable results regarding the development of sustained unresponsiveness in children younger than 4 years [35], and this is confirmed also in studies of epicutaneous immunotherapy (EPIT) [36,37]. Immune system immaturity and plasticity during infancy may be the reason. ...

Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent

Journal of Allergy and Clinical Immunology

... 14 clinicians need to be aware of the heterogeneous clinical manifestations of ieis so that early diagnosis and prompt treatment can be engaged, resulting in a better outcome. 15 the potential for discoveries in the field of IEIs is vast, and as our knowledge expands, so will do the possibilities for developing new treatments and management options, eventually improving the Quality of Life for individuals affected by iei but also for patients suffering from highly prevalent polygenic diseases which share the same pathogenetic mechanisms. ...

Clinical updates in inborn errors of immunity: a focus on the noninfectious clinical manifestations
  • Citing Article
  • January 2024

Current Opinion in Pediatrics

... 42 Importantly, shared decision-making is appropriate under conditions of equipoise. 48,49 This fact acknowledges that there are often circumstances in which a strong medical recommendation directs a course of action that is highly likely to result in best health (and sometimes health economic) outcomes. 47 Fortunately, contemporary guidelines provide clear navigational signals for when shared decision-making may be appropriate (i.e., conditional "suggestions") and when clinical circumstances are not preference sensitive (i.e., strong recommendations). ...

Treating the patient in front of you
  • Citing Article
  • January 2024

Annals of Allergy Asthma & Immunology

... Additionally, the lack of significant variation in patients with prior VZV infection or reactivation or a history of neoplasms is somewhat unexpected. These conditions are generally considered contraindications or complicating factors for initiating treatment with JAK inhibitors [76]. Reactivations of VZV have been solidly documented in RCTs of JAK inhibitors, underscoring the immunosuppressive effects of these therapies [77][78][79]. ...

Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations
  • Citing Article
  • December 2023

Annals of Allergy Asthma & Immunology

... Introducing diverse complementary foods during infancy not only supports optimal growth and development but also serves a critical role in immune system maturation [1]. Consequently, the AAP later revised its guidelines, advising against food restrictions and advocating for the early introduction of assorted foods [6,7]. ...

Updates in Food Allergy Prevention in Children
  • Citing Article
  • October 2023

... 8 However, additional real-world clinical data are needed to demonstrate if these desirable outcomes are truly achievable with early age peanut oral immunotherapy (epOIT). 9 This study examines both the effectiveness and safety of peanut OIT in children less than 3 years old at epOIT start in a real-world academic clinical setting and was approved under University of Virginia School of Medicine Approved Protocol (IRB #24604). ...

Real-world data are critical for the implementation of preschool food allergen immunotherapy
  • Citing Article
  • August 2023

The Journal of Allergy and Clinical Immunology In Practice